V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290002967 | 290002220 | 0 | null | Adjuvant (A) | 2013-10-08 | 2013-10-31 | Cisplatin 7 day | N | Y | 290018476 | CISPLATIN |
| 290002968 | 290002221 | null | 73.2 | Palliative (P) | 2016-05-10 | 2016-05-10 | IMATINIB | N | N | 290018478 | IMATINIB |
| 290002969 | 290002222 | 1.85 | 83.6 | Curative (C) | 2017-04-16 | 2017-05-14 | Cisplatin 7 day | N | Y | 290018481 | CISPLATIN |
| 290002970 | 290006218 | 1.58 | 73 | Adjuvant (A) | 2016-10-10 | 2016-10-18 | IMATINIB | N | N | 290018484 | IMATINIB |
| 290002971 | 290002223 | 1.68 | 60 | Curative (C) | 2017-08-18 | 2017-09-19 | Capecitabine + Mitomycin | N | Y | 290018485 | CAPECITABINE + MITOMYCIN |
| 290002972 | 290002224 | 1.79 | 61.5 | Palliative (P) | 2016-07-02 | 2016-07-26 | Imatinib 400mg | N | N | 290018486 | IMATINIB |
| 290002973 | 290002225 | 1.62 | 64.4 | Curative (C) | 2014-11-20 | 2014-12-15 | Capecitabine + Mitomycin | N | Y | 290018487 | CAPECITABINE + MITOMYCIN |
| 290002974 | 290002226 | 1.65 | 61.7 | Disease modification (D) | 2015-07-24 | 2015-07-24 | Imatinib 400mg | 99 | null | 290018489 | IMATINIB |
| 290002975 | 290006219 | 1.76 | 79.3 | Curative (C) | 2013-10-03 | 2013-10-20 | Oxaliplatin + Modified de Gramont | 02 | N | 290018490 | OXALIPLATIN + MDG |
| 290002976 | 290006219 | 1.66 | 56.1 | null | null | 2016-05-25 | IMATINIB | 02 | N | 290018490 | IMATINIB |
| 290002977 | 290006219 | 1.58 | 69 | Adjuvant (A) | 2016-01-05 | 2016-01-05 | Imatinib 400mg | N | N | 290018490 | IMATINIB |
| 290002978 | 290002227 | -1 | null | Adjuvant (A) | 2015-09-13 | 2015-09-29 | Capecitabine + Mitomycin | N | Y | 290018494 | CAPECITABINE + MITOMYCIN |
| 290002979 | 290002228 | 1.79 | 69 | Curative (C) | 2016-07-28 | 2016-08-23 | FLUOROURACIL + MITOMYCIN | 02 | null | 290018495 | FLUOROURACIL + MITOMYCIN |
| 290002980 | 290002228 | 1.61 | 61.3 | Not known (9) | 2016-07-12 | 2016-08-03 | Capecitabine + Mitomycin | Y | Y | 290018495 | CAPECITABINE + MITOMYCIN |
| 290002981 | 290002229 | 1.61 | 67.55 | Adjuvant (A) | 2018-04-15 | 2018-04-16 | Cisplatin 7 day | 02 | Y | 290018501 | CISPLATIN |
| 290002982 | 290002229 | null | 103.6 | Curative (C) | 2017-04-21 | 2017-05-05 | Capecitabine + Mitomycin | N | Y | 290018501 | CAPECITABINE + MITOMYCIN |
| 290002983 | 290007635 | 1.84 | 82.7 | Adjuvant (A) | 2014-09-10 | 2014-09-25 | Oxaliplatin + Modified de Gramont | 2 | N | 290018506 | OXALIPLATIN + MDG |
| 290002984 | 290007635 | 1.53 | 71 | Curative (C) | 2013-04-08 | 2013-04-22 | FLUOROURACIL + OXALIPLATIN | 02 | N | 290018506 | OXALIPLATIN + MDG |
| 290002985 | 290002230 | null | 88.95 | null | 2016-06-21 | 2016-06-21 | Oxaliplatin + Modified de Gramont | 02 | N | 290018509 | OXALIPLATIN + MDG |
| 290002986 | 290002230 | 1.67 | 66 | Palliative (P) | 2013-04-30 | 2013-05-21 | Cisplatin 7 day | N | Y | 290018509 | CISPLATIN |
| 290002987 | 290002230 | 1.58 | 46 | Curative (C) | 2016-08-17 | 2016-08-31 | Capecitabine + Mitomycin | N | Y | 290018509 | CAPECITABINE + MITOMYCIN |
| 290002988 | 290002231 | 1.73 | 74.6 | Adjuvant (A) | 2017-03-16 | 2017-03-16 | Imatinib 400mg | 02 | N | 290018512 | IMATINIB |
| 290002989 | 290002232 | 1.61 | 49.2 | Curative (C) | 2016-03-08 | 2016-03-20 | Capecitabine + Mitomycin | N | Y | 290018513 | CAPECITABINE + MITOMYCIN |
| 290002990 | 290002233 | 1.63 | 73.55 | Curative (C) | null | 2016-06-20 | Capecitabine + Mitomycin | N | n | 290018519 | CAPECITABINE + MITOMYCIN |
| 290002991 | 290002234 | null | null | Curative (C) | 2014-08-01 | 2014-08-09 | Capecitabine + Mitomycin | 02 | Y | 290018520 | CAPECITABINE + MITOMYCIN |
| 290002992 | 290002235 | 1.69 | null | Adjuvant (A) | 2013-12-01 | 2013-12-01 | Imatinib 400mg | N | N | 290018521 | IMATINIB |
| 290002993 | 290002236 | 0 | 68 | Curative (C) | 2016-08-14 | 2016-09-15 | Cisplatin | 02 | N | 290018522 | CISPLATIN |
| 290002994 | 290002237 | 1.59 | 84.1 | Adjuvant (A) | 2016-05-27 | 2016-05-31 | Oxaliplatin + Modified de Gramont | 02 | N | 290018523 | OXALIPLATIN + MDG |
| 290002995 | 290002238 | null | null | null | 2014-08-28 | 2014-09-24 | Capecitabine + Mitomycin | N | Y | 290018525 | CAPECITABINE + MITOMYCIN |
| 290002996 | 290002239 | 1.8 | 87.4 | Curative (C) | 2013-08-07 | 2013-08-20 | FLUOROURACIL + MITOMYCIN | 02 | N | 290018526 | FLUOROURACIL + MITOMYCIN |
| 290002997 | 290002239 | 1.55 | 77 | Curative (C) | 2015-01-14 | 2015-01-21 | Oxaliplatin + Modified de Gramont | 02 | N | 290018526 | OXALIPLATIN + MDG |
| 290002998 | 290002239 | 1.61 | 67.1 | null | 2015-08-15 | 2015-09-02 | Oxaliplatin + Modified de Gramont | 2 | N | 290018526 | OXALIPLATIN + MDG |
| 290002999 | 290002240 | 1.58 | 53 | null | 2016-05-13 | 2016-05-13 | FLUOROURACIL + OXALIPLATIN | N | N | 290018531 | OXALIPLATIN + MDG |
| 290003000 | 290002241 | 1.67 | 66.3 | Curative (C) | 2013-07-30 | 2013-08-05 | Capecitabine + Mitomycin | N | Y | 290018532 | CAPECITABINE + MITOMYCIN |
| 290003001 | 290002242 | 1.98 | null | Curative (C) | 2014-03-08 | 2014-03-21 | FLUOROURACIL + MITOMYCIN | 02 | null | 290018535 | FLUOROURACIL + MITOMYCIN |
| 290003002 | 290002243 | 1.56 | 44 | Curative (C) | 2017-07-02 | 2017-07-27 | Capecitabine + Mitomycin | N | Y | 290018536 | CAPECITABINE + MITOMYCIN |
| 290003003 | 290002244 | 0 | 80 | Curative (C) | 2017-11-20 | 2017-12-02 | FLUOROURACIL + MITOMYCIN | null | null | 290018537 | FLUOROURACIL + MITOMYCIN |
| 290003004 | 290002245 | 1.66 | 69.1 | Curative (C) | 2016-03-26 | 2016-03-26 | Cisplatin 7 day | N | Y | 290018538 | CISPLATIN |
| 290003005 | 290002246 | 1.83 | 82.4 | Adjuvant (A) | 2017-12-16 | 2017-12-21 | Imatinib 400mg | 02 | N | 290018539 | IMATINIB |
| 290003006 | 290002247 | 1.7 | 83 | Curative (C) | 2016-09-15 | 2016-10-09 | Capecitabine + Mitomycin | N | Y | 290018541 | CAPECITABINE + MITOMYCIN |
| 290003007 | 290002248 | 0 | 73 | Neo-adjuvant (N) | 2015-05-15 | 2015-05-15 | Imatinib 400mg | N | N | 290018542 | IMATINIB |
| 290003008 | 290002249 | 1.57 | 70.6 | Curative (C) | 2015-02-18 | 2015-03-02 | Capecitabine + Mitomycin | 02 | Y | 290018543 | CAPECITABINE + MITOMYCIN |
| 290003009 | 290002250 | 1.56 | 82.4 | Adjuvant (A) | 2014-11-10 | 2014-11-16 | FLUOROURACIL + OXALIPLATIN | N | N | 290018544 | OXALIPLATIN + MDG |
| 290003010 | 290002251 | 1.74 | 56.3 | Adjuvant (A) | 2016-11-07 | 2016-11-07 | Imatinib 400mg | N | N | 290018545 | IMATINIB |
| 290003011 | 290002252 | 1.6 | 66.5 | Neo-adjuvant (N) | 2016-06-04 | 2016-06-05 | IMATINIB | 02 | N | 290018548 | IMATINIB |
| 290003012 | 290002253 | 1.58 | 56.7 | Curative (C) | 2017-03-25 | 2017-04-08 | Capecitabine + Mitomycin | N | N | 290018549 | CAPECITABINE + MITOMYCIN |
| 290003013 | 290002254 | 1.87 | null | Curative (C) | 2013-05-10 | 2013-06-06 | Capecitabine + Mitomycin | N | Y | 290018551 | CAPECITABINE + MITOMYCIN |
| 290003014 | 290002255 | 1.56 | null | Palliative (P) | 2017-01-31 | 2017-01-31 | Imatinib 400mg | 02 | N | 290018553 | IMATINIB |
| 290003015 | 290002256 | 1.65 | 52 | Adjuvant (A) | null | 2016-05-31 | Imatinib 400mg | 02 | null | 290018555 | IMATINIB |
| 290003016 | 290002257 | 1.74 | 83.45 | Neo-adjuvant (N) | 2016-10-25 | 2016-11-27 | Capecitabine + Mitomycin | N | Y | 290018558 | CAPECITABINE + MITOMYCIN |